Study S001595

Preliminary Safety and Efficacy of Semaglutide and Naltrexone Combination Therapy for Alcohol Use Disorder

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07249554
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 45
Start: 2026-11
Primary completion: 2028-07
Lead sponsor: Johns Hopkins University
Conditions: Alcohol Use Disorder
Interventions: DRUG:Placebo; DRUG:Glucagon-Like Peptide-1 Agonist (GLP-1); DRUG:Naltrexone (oral tablets)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Participant-reported Adverse Events [14 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.